Tyra Biosciences, Inc. (TYRA) Free cash flow 2020–2025
Tyra Biosciences, Inc. (TYRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$95.3MFY2025 · since FY2020: -$8.1M → -$95.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$95.3M | -35.3% |
| FY2024 | -$70.4M | -38.4% |
| FY2023 | -$50.9M | -0.1% |
| FY2022 | -$50.8M | -108.3% |
| FY2021 | -$24.4M | -202.2% |
| FY2020 | -$8.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TYRA financial trends
TYRA RevenueTYRA Net incomeTYRA Net marginTYRA Gross profitTYRA Gross marginTYRA Operating incomeTYRA Operating marginTYRA Operating cash flowTYRA Capital expendituresTYRA Return on equityTYRA Stock buybacksTYRA Dividends paidTYRA Total assetsTYRA Total liabilitiesTYRA Shareholders’ equityTYRA overview →